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ABSTRACT
The protective effect of bovine somatotropin (bST)
during experimental Streptococcus uberis mastitis in
cows was studied. The left quarters of 10 cows were
infected with 500 cfu of S. uberis O140J. Five cows
were subcutaneously treated with 500 mg of recom-
binant bST 7 d before and after infection, and 5
control cows received the excipient. In the treated
cows, total milk production significantly increased
after the first and second bST treatments. After infec-
tion, milk production decreased 24 and 40% in the
infected quarters, 6 and 14% in the uninfected quart-
ers, and 15 and 28% overall for treated and control
cows, respectively. In the bST group, milk production
was completely restored after 3 wk, but, in the control
group, total production and the production of the
infected quarters remained lower than preinfection
production. The increase in somatic cell count oc-
curred earlier and more rapidly in the control group,
and the return to normal values was also more rapid
in these cows. The amount of bacteria in milk was
higher in the control cows. Changes in milk composi-
tion, such as lactose, protein, fat, Na+, K+, and Cl±,
were significantly more pronounced in the control
cows. Also, clinical symptoms were more prominent in
the control cows. Somatotropin protected the mam-
mary gland from excessive production losses and com-
positional changes during a subsequent episode of
experimentally induced Streptococcus uberis mastitis
and significantly improved the normalization of
production and composition, which indicates a benefi-
cial effect on the restoration of the integrity of the
blood-milk barrier.
( Key words: Streptococcus uberis mastitis, recom-
binant bovine somatotropin, milk production, milk
composition)
Abbreviation key: MP = milk production.
INTRODUCTION
Mastitis is economically the most important dis-
ease in the dairy industry (39) because of the costs of
prevention and curative treatment, veterinary serv-
ices, culling, technical problems in milk processing,
increased labor, and large production losses (15).
Because the hygiene on well-managed dairy farms
has improved, the relative incidence of infectious
mastitis, such as Staphylococcus aureus mastitis, has
decreased, and the relative incidence of environmen-
tal mastitis, such as coliform and Streptococcus uberis
mastitis, has increased (18, 40). Recombinant bST
protected the mammary gland from excessive milk
production ( MP) losses during a subsequent ex-
perimentally induced Escherichia coli mastitis (47)
in cows. Normalization of MP and milk composition
was accelerated by bST, especially in severely dis-
eased cows (47). Moreover, during cases of E. coli
mastitis in cows, increased concentrations of bST,
insulin, and cortisol have been observed (48). Ad-
ministration of bST to dairy cows significantly in-
creases MP. Depending on the stage of lactation,
production increases of 10 to 15% have been reported
(28, 31, 45).
The purpose of the present study was to investigate
whether the protective role of pretreatment with
recombinant bST during experimentally induced E.
coli mastitis could also be observed during experimen-
tally induced S. uberis mastitis, which has a com-
pletely different pathogenesis. Indeed, acute E. coli
mastitis after calving is accompanied by severe sys-
temic symptoms, especially in the so-called severe
responders (47), with, in some cases, even shock and
death. These severe systemic signs are not observed
during S. uberis mastitis, which is characterized by
local mastitis symptoms and very few systemic sym-
ptoms (16). In addition, neutrophils are of major
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importance in the pathogenesis of E. coli mastitis, but
contribute little to the pathogenesis of S. uberis
mastitis (16, 17). Moreover, antibiotic treatment of
acute coliform mastitis always comes too late, but is
necessary to cure streptococcal mastitis. We studied
whether bST was important in the homeostasis of
inflammation of the bovine mammary gland and in
the subsequent loss of function. Therefore, an inflam-
matory model of the mammary gland infected with S.
uberis, which has a different pathogenesis than E. coli
mastitis, was used.
MATERIALS AND METHODS
Cows
Ten East Flemish Red Pied cows that were in their
first lactation, clinically healthy, and free of mastitis
were selected. At the start of the experiment, the cows
were between 6 and 15 wk postpartum. Before these
cows were purchased, the mammary gland was exa-
mined clinically, and milk samples were analyzed
from each quarter. Only those cows with an SCC less
than 2 × 105/ml for each mammary quarter sample
that were negative for mastitis pathogens were
selected. Mean SCC before infection was 47 × 103 ± 6
× 103/ml. During the experiment, the cows were
housed in individual tie stalls. Cows were transferred
to these stalls 1 wk before the start of the experiment
to allow acclimation. Cows were fed a daily ration of
approximately 8 kg of concentrate and had ad libitum
access to water and hay. Cows were fed twice daily at
0630 and 1630 h, which did not overlap with sam-
pling or treatment. Cows were milked twice daily at
0700 and 1700 h with a device that measures in-
dividual mammary gland quarter milk production.
Mean MP before the first treatment was 16.8 ± 0.2 kg/
d.
Inoculation Procedure
A S. uberis strain O140J (James Leigh, Compton,
UK), which is a phagocytosis-resistant strain in the
presence of casein (25, 26), was maintained in a
lyophilization medium at ±20°C. For experimental
use, the bacteria were subcultured in Todd Hewitt
broth (Lab M, Bury, UK) at 37°C for 18 h. After
washing, the organisms were resuspended and
diluted in pyrogen-free PBS. On d 0, 1 h after the
morning milking, the cows were inoculated in the left
front and left rear quarters with a suspension con-
taining approximately 500 cfu of S. uberis O140J in a
total volume of 20 ml of sterile pyrogen-free saline
solution per quarter. The bacterial suspension was
inoculated into the teat cistern using a sterile teat
cannula. Before inoculation, the teat ends were disin-
fected with 70% ethanol containing 0.5% chlorhexi-
dine. After the inoculation, each quarter was mas-
saged for 30 s to distribute the bacterial suspension in
the mammary gland.
EXPERIMENTAL DESIGN
All cows were experimentally infected with 500 cfu
of S. uberis at d 0 of the experiment. Five cows were
injected subcutaneously into the ischiorectal fossa
with 500 mg of recombinant bST (Posilac; Monsanto
Co., St. Louis, MO) 7 d before infection (d ±7) and 7
d after infection (d +7). Similarly, five control cows
were also subcutaneously injected with the excipient
on the same days. The experiment consisted of four
different periods: an 8-d period before the first injec-
tion (d ±7), a 7-d period between the first treatment
and infection (d 0), a 7-d period after the infection
and before the second treatment (d +7), and a
3-wk period after the second treatment. A mixture
(Nafpenzal; Mycofarm Belga, Turnhout, Belgium)
of sodium nafcillin (100 mg), sodium penicillin G
(300,000 U), and dihydrostreptomycin sulfate (100
mg) was injected once daily into the infected quarters
of all cows 48 h after the first appearance of clinical
symptoms. This intramammary antibiotic treatment
was continued for 3 consecutive d at 24-h intervals.
Milk Sampling Schedule
Milk samples were aseptically collected from each
individual mammary quarter for bacteriological ex-
amination. Samples also were collected for determina-
tion of milk SCC, fat, total protein, lactose, Na+, K+,
Cl±, and BSA. These samples were collected once
daily at the morning milking on d ±8, ±4, ±1, +6, +7,
+8, +9, +14, +21, and +28. On d 0, +1, +2, and +3, milk
samples were collected at 0700, 1400, and 2000 h. For
bacteriological examination of the milk, the samples
taken aseptically were immediately streaked out on a
blood agar plate made of sheep red blood cells using
an inoculation loop of 10 ml and incubated at 37°C.
Scoring of the bacterial growth was completed 24 h
after inoculation by simply counting the number of
colonies grown on the plate. Separate milk samples
were kept at 4°C and sent to the Belgian Society for
Milk Quality (Lier) for determination of SCC, fat,
protein, and lactose content. Remaining samples were
used to prepare skim milk by centrifugation at 1000 ×
g for 15 min. After the fat layer was discarded, the
skim milk was divided in aliquots and stored at ±20°C
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Figure 1. Changes in total milk production (MP) of recombinant
bST-treated cows ( Ú) and control cows ( ×) during experimentally
induced ( „) Streptococcus uberis mastitis. Data are means of five
cows, and error bars represent the standard errors of the means.
Weeks relative to infection: ±2 = week before first treatment (ar-
row), ±1 = week after first treatment and before infection, 1 = 1st
week after infection and before second treatment (arrow), 2 = 1st
wk after second treatment, 3 = 2nd wk after second treatment, and
4 = 3rd wk after second treatment.
until further analyses. The MP was measured for
each individual quarter.
Observations and Analyses
Somatic cell count was determined for each in-
dividual quarter by means of the fluoro-opto-
electronic cell counting principle (Fossomatic 360;
Foss Electronic, Eden Prairie, MN), which is based
on the binding of ethidium bromide to DNA. For
statistical analysis, geometric means were used. Lac-
tose, protein, and fat concentrations of quarter milk
samples were determined by the infrared spec-
trophotometric principle (MilkoScan 4000; Foss
Electronic). Sodium, K+, and Cl± were analyzed using
ion selective electrodes (Ilyte; Instrumentation
Laboratory, Zaventem, Belgium). Bovine serum albu-
min concentrations in milk were analyzed according
to the method of Guzman et al. (14), which is based
on a colorimetric method using bromocresol green,
NaOH, and lactic acid.
Cows and quarters were also clinically investigated
at each sample collection. Rectal temperature, heart
rate, feed intake, and forestomach motility were
monitored. Observations on experimentally infected
and control quarters included pain, firmness, and
swelling of quarters and appearance of milk.
Statistical Analyses
Means, standard deviations, and standard errors of
the means were calculated using the statistical analy-
sis program package Statistix (42). Statistical anal-
ysis of all data was performed using an ANOVA
(mixed linear model) with the following model: Y = m
+ T + t + C/T + Int1 + Int2 + e, where Y = dependent
variable, m = overall mean, T = treatment, t = time, C/
T = cow nested within treatment, Int1 = interaction
between treatment and time (T × t), Int2 = interac-
tion between the cows nested within the treatment
and the time (C/T × t), and e = experimental error
term. Treatment and time were fixed variables, and
individual cows were randomized variables, which
were nested within the treatment. To study the ef-
fects of treatment, the error term was C/T. To study
the effects of time, the Int2 term was the error term.
After running the ANOVA, general contrasts were
calculated. Significant differences were determined at
P < 0.05, P < 0.01, and P < 0.001.
RESULTS
Total MP
In the bST-treated cows (Figure 1), total MP in-
creased ( P < 0.01) 10% after the first treatment.
During wk +1, total MP decreased 15 and 28% for the
treated ( P > 0.05) and the control groups ( P < 0.01).
At d +2, the maximal decrease was 23 and 36% in the
treated and control groups. Total MP of the control
cows during wk +1 was much lower ( P < 0.001) than
preinfection MP values. From d +6, MP started to
increase ( P < 0.05) in both groups. During the last
week of the experiment (wk +4), total MP decreased
( P < 0.01) by 11% in the treated cows compared with
the MP during the 14 d after the second treatment.
The MP of the control cows during wk +4 was about
15% lower ( P < 0.05) than the MP at the start of the
trial. The MP during wk +4 was lower than the MP
during the week before infection in the bST-treated
cows ( P < 0.01) and the control cows ( P < 0.05). The
recovery of total MP 4 wk after infection was complete
in the treated cows. Total MP of the treated cows
after the second treatment equaled the MP after the
first treatment. In contrast, MP of the control cows
during the 2nd wk postinfection remained lower ( P <
0.01) than that before infection. Total MP preinfec-
tion was higher (21%; P < 0.001) than overall postin-
fection MP for the control cows. In the treated cows,
overall MP after infection slightly increased by 7%.
When total MP of the two groups at the different
periods was compared, differences ( P < 0.05) between
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Figure 2. Changes in milk production (MP) of the infected
quarters of recombinant bST-treated cows ( Ú) and control cows ( ×)
during experimentally induced ( „) Streptococcus uberis mastitis.
Data are means of five cows, and error bars represent the standard
errors of the means. Weeks relative to infection: ±2 = week before
first treatment (arrow), ±1 = week after first treatment and before
infection, 1 = 1st week after infection and before second treatment
(arrow), 2 = 1st wk after second treatment, 3 = 2nd wk after second
treatment, and 4 = 3rd wk after second treatment.
groups could be observed at the start of the trial and
during wk +1 and +2.
MP of the Infected Quarters
The changes in the MP of infected quarters were
similar to those for the total MP, although they were
more pronounced (Figure 2). The MP of infected
quarters after infection declined by 24 ( P > 0.05) and
40% ( P < 0.01) in the treated and control group
during wk +1. The maximal decrease was observed on
d +2 in both the treated (30%) and control cows
(46%). In the control cows, the MP of infected quart-
ers during wk +1 was lower ( P < 0.001) than the MP
before infection. Around d +6, MP started to increase
in both groups. In the control group, the MP during
wk +3 further increased ( P < 0.001) compared with
the MP during wk +1. The MP of the treated cows
increased during 2 wk after the second treatment but
decreased ( P < 0.05) by 11% during the 3rd wk after
the second treatment.
During wk +4, MP was 26% ( P < 0.05) lower than
the MP before the first treatment in the control cows
and 17% lower for the treated cows ( P > 0.05). The
recovery in the treated cows was already complete
during wk +2. The MP during 3 wk after the second
bST treatment was lower ( P < 0.001) than the MP
before infection for the control cows. In the treated
cows, MP after the first treatment was similar to MP
during the 2 wk after the second treatment. The MP
during wk +2 and +3 in the control cows was still
lower ( P < 0.01) than the MP before infection. The
MP of infected quarters in the control cows during the
preinfection period was greater (43%) than that dur-
ing the total postinfection period ( P < 0.001). The
difference in the treated group was 18% ( P > 0.05).
MP in the Contralateral Control Quarters
Only minor changes in the MP of control quarters
could be observed (Figure 3). After the first bST
treatment, MP of contralateral quarters increased ( P
< 0.01) by 12%. After infection, MP of contralateral
quarters decreased 6 and 14% in the treated ( P >
0.05) and control ( P < 0.05) cows compared with
preinfection MP. During the 2nd wk postinfection,
MP was increased in both the treated ( P > 0.05)
(9%) and the control groups (17%; P < 0.05). During
the 4th wk postinfection, the MP of treated cows
decreased 11% ( P < 0.001) compared with a 6% ( P <
0.05) decrease for control cows.
Recovery of MP in contralateral control quarters to
preinfection levels was complete in both groups. The
MP by the treated cows after the first and second
treatments was higher ( P < 0.01) in comparison with
the MP before the first treatment. Preinfection MP of
contralateral quarters did not differ ( P > 0.05) from
the overall postinfection MP for either group.
Milk SCC
In both groups, SCC (geometric means) in the
infected quarters started to increase after infection
(Figure 4). This increase was more pronounced in the
control cows. The SCC peaked at 36 h postinfection in
the control group ( P < 0.001) and between approxi-
mately 78 and 96 h postinfection in the bST-treated
group ( P < 0.01). The SCC remained at a very high
level from 24 to 9 d after infection in the control cows.
During the first 24 h after infection, SCC increased in
the treated cows ( P < 0.05) and in the control cows
( P > 0.05). During the next 24 h (24 to 48 h postin-
fection), SCC further increased in the treated group
( P > 0.05) and the control group ( P < 0.001). This
increase ( P < 0.01) continued until 96 h after infec-
tion in the treated cows. From d +6, SCC started to
decrease ( P < 0.01) in the treated cows. At the end of
the experiment, however, SCC was still higher ( P <
0.05) compared with preinfection value in the treated
group. In the control cows, normal SCC was recovered
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Figure 3. Changes in milk production (MP) of contralateral
control quarters of recombinant bST-treated cows ( Ú) and control
cows ( ×) during experimentally induced ( „) Streptococcus uberis
mastitis. Data are means of five cows, and error bars represent the
standard errors of the means. Weeks relative to infection: ±2 =
week before first treatment (arrow), ±1 = week after first treat-
ment and before infection, 1 = 1st wk after infection and before
second treatment (arrow), 2 = 1st wk after second treatment, 3 =
2nd wk after second treatment, and 4 = 3rd wk after second
treatment.
Figure 4. Changes in milk SCC of the infected quarters of
recombinant bST-treated cows ( Ú) and control cows ( ×) during
experimentally induced Streptococcus uberis mastitis. Data are
means of five cows, and error bars represent the standard errors of
the means. Geometric means were calculated. Periods: ±1 = d ±8
until 0 h, 0 = 6 to 24 h after infection, 1 = 30 to 48 h after infection,
2 = 54 to 72 h after infection, 3 = from 78 to 96 h after infection, 4 =
d +6 to +9, 5 = d +14 to +28.
completely. Thus, an increase in SCC after infection
occurred earlier and more rapidly in the control group
than in the bST-treated group, but the return to
normal values at the end of the experiment also was
more rapid in the control cows. From d +14, SCC was
higher ( P > 0.05) in the treated cows than in the
control cows. Between d +14 and + 28, SCC stabilized
in the treated cows but remained higher ( P < 0.05)
than before infection. In the control cows, however, a
decrease ( P < 0.01) was observed between d +14 and
+ 28 to values that did not differ ( P > 0.05) from
preinfection values.
The SCC in the infected quarters was higher in
control cows than in the treated cows on d +2 ( P <
0.001), +3 ( P < 0.05), and d +6 to +9 ( P < 0.05).
Milk Bacterial Counts
Significant differences in the number of bacteria in
the milk of the infected quarters were observed only
between 48 and 84 h after infection (Figure 5). Dur-
ing this period, the amount of bacteria was higher in
the control cows, especially between 78 and 84 h after
infection ( P < 0.001). During the first 24 h after
infection, the amount of bacteria in milk increased ( P
< 0.001) for cows in both groups. On d +6, the amount
of bacteria increased ( P < 0.01) in the treated cows.
From d +14, the amount of bacteria decreased ( P <
0.01) again in both groups compared with the counts
between d +7 and +14. By the end of the experiment,
the bacterial amount did not differ ( P >0.05) from
preinfection numbers.
Milk Lactose
No changes ( P > 0.05) in the lactose concentration
occurred in the contralateral control quarters (Table
1). The two groups only differed at d +2 ( P < 0.05),
which was due to a sudden decrease in milk lactose in
the control cows at 36 h after infection.
Based on mammary quarters, numerous changes
occurred (Figure 6). Beginning at 24 h after infec-
tion, the lactose concentration decreased by 35% in
the infected quarters of control cows ( P < 0.01) but
did not change in bST-treated cows. From 48 to 84 h
postinfection, lactose concentration continued to
decrease ( P < 0.01) in the control cows; the lowest
concentration was reached between 48 and 72 h after
infection ( P < 0.001). Milk lactose concentration from
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Figure 5. Changes in bacterial count in the infected quarters of
recombinant bST-treated cows ( Ú) and control cows ( ×) during
experimentally induced Streptococcus uberis mastitis. Data are
means of five cows, and error bars represent the standard errors of
the means. Periods: ±1 = d ±8 until 0 h, 0 = 6 to 24 h after infection,
1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection, 3 = from
78 to 96 h after infection, 4 = d +6 to +9, 5 = d +14 to +28.
the treated cows decreased ( P > 0.05) between 48 and
72 h postinfection. By 72 h postinfection, lactose con-
centration started to increase again. The concentra-
tion between d +6 and +9 was lower ( P < 0.05) than
the preinfection concentration for both groups. A
return to normal lactose concentrations was not
achieved in either group compared with the preinfec-
tion concentration ( P < 0.05).
For the control cows, the concentration of lactose
before infection was higher ( P < 0.001) than the
concentration during the entire postinfection period,
but, for the treated cows, no difference ( P > 0.05)
could be observed between these two periods.
The concentration of milk lactose from the two
groups of cows differed on d +1 (30 to 48 h; P < 0.01),
+2 (54 to 72 h; P < 0.001), and +3 (78 to 84 h; P <
0.05).
Milk Fat
The concentration of milk fat in the infected quart-
ers of the control cows decreased by 25% during the
first 24 h after infection ( P > 0.05). This decrease
was followed by an increase ( P < 0.05) between 30
and 72 h postinfection. By d +6, the fat concentration
in the infected quarters of the control cows normal-
ized. No changes ( P > 0.05) were observed for the
treated cows. For the control cows, fat concentration
of milk from the control quarters increased ( P <
0.01), peaking between 54 and 72 h postinfection.
This increase was followed by a decrease and a nor-
malization by d +9. No changes ( P > 0.05) could be
observed for the treated cows. Recovery of milk fat in
the treated and control quarters was complete for
both groups. The fat concentration in the infected and
the control quarters before infection did not differ ( P
> 0.05) from the concentration observed during the
complete postinfection period for both groups.
Milk Protein
During the first 72 h postinfection, no changes ( P >
0.05) in milk protein concentration took place in the
infected quarters of the treated cows (Figure 7). At
72 h postinfection, total milk protein increased ( P <
0.01) by 11%. From d +7, the concentration started to
decrease but still remained higher ( P < 0.05) than
preinfection concentrations, even on d +28 ( P < 0.01).
The concentration before infection did not differ from
the concentration during the entire postinfection
period. Treatment with bST on d ±7 and +7 had no
effect on total protein concentration in the infected
quarters.
In the control cows, milk protein in the infected
quarters was not altered during the first 24 h after
infection. By 30 h postinfection, milk protein had
increased ( P < 0.05) by 29% with a dramatic increase
at 48 h postinfection. Although protein concentration
decreased after d +3, it still remained higher ( P <
0.01) than the preinfection concentration until the
end of the experiment. Between 54 and 72 h postin-
fection, protein concentration in milk from the control
cows was higher ( P < 0.001) than that in milk from
the treated cows. Overall concentrations in the con-
trol quarters of both the treated and the control
groups were unaffected during the experiment (Table
1).
BSA
Milk BSA increased ( P < 0.01) during the first 24
h after infection in both groups (Figure 8). During
the next 24 h, the concentration further increased in
the control group ( P < 0.01) and the treated group ( P
> 0.05). Between 48 and 72 h postinfection, BSA
increased in the treated group ( P < 0.05) but not ( P >
0.05) in the control cows. The greatest increase ( P <
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TABLE 1. Milk composition in the contralateral control quarters of the bST-treated and control cows during the different periods of the
experiment.1
1Data are means of five cows ± SEM. Each cow was experimentally infected with 500 cfu S. uberis O140J (J. Leigh, Compton, U.K.)
into the left quarters. Five bST-treated cows were subcutaneously treated with 500 mg of recombinant bST (Posilac, Monsanto Co., St.
Louis, MO) 7 d before and after infection; 5 control cows received the excipient.
Milk
constituent2
Preinfection Postinfection
±192 to 0 h 6 to 24 h 30 to 48 h 54 to 72 h 78 to 84 h 144 to 216 h 336 to 672 h
Lactose (g/L) bST 50.0 ± 0.7 50.2 ± 0.5 50.5 ± 0.8 51.0 ± 0.4 50.1 ± 1.4 50.3 ± 0.9 49.6 ± 0.8
Control 50.4 ± 1.2 49.9 ± 1.2 47.9 ± 1.6 50.3 ± 0.8 47.9 ± 2.3 49.6 ± 1.2 49.2 ± 1.0
Fat (g/L) bST 43.7 ± 2.4 41.5 ± 3.4 51.0 ± 3.1 45.1 ± 3.3 44.5 ± 1.4 40.5 ± 5.9 36.5 ± 4.8
Control 38.1 ± 4.1 40.9 ± 3.9 50.5 ± 5.0 53.5 ± 5.4 50.7 ± 11.3 43.6 ± 1.8 39.1 ± 3.4
Protein (g/L) bST 32.3 ± 1.13 32.2 ± 1.20 31.6 ± 1.71 32.1 ± 1.72 32.9 ± 1.68 32.6 ± 1.17 33.6 ± 0.92
Control 32.2 ± 0.82 32.5 ± 0.89 31.9 ± 0.86 30.7 ± 1.49 30.7 ± 2.12 32.6 ± 0.83 33.4 ± 0.88
BSA (g/L) bST 0.68 ± 0.27 0.87 ± 0.88 1.09 ± 0.10 1.58 ± 0.16 1.00 ± 0.19 1.51 ± 0.13 1.32 ± 0.19
Control 0.63 ± 0.13 0.79 ± 0.73 1.09 ± 0.15 1.07 ± 0.14 0.82 ± 0.58 1.41 ± 0.40 1.01 ± 0.73
Na+ (mM) bST 14.2 ± 0.62 15.5 ± 1.70 13.8 ± 0.99 15.3 ± 1.07 14.9 ± 0.74 15.9 ± 0.96 14.7 ± 1.00
Control 15.2 ± 0.67 13.8 ± 0.32 20.1 ± 4.51 16.4 ± 0.79 16.5 ± 0.67 19.6 ± 2.12 14.7 ± 0.26
K+ (mM) bST 40.8 ± 1.08 37.6 ± 0.69 36.5 ± 1.37 40.1 ± 1.32 40.2 ± 1.14 39.4 ± 1.45 40.1 ± 1.20
Control 41.8 ± 1.65 34.6 ± 1.63 36.7 ± 1.08 40.2 ± 0.95 39.8 ± 1.99 40.0 ± 1.14 41.2 ± 0.72
Cl± (mM) bST 24.4 ± 1.60 25.4 ± 1.40 24.2 ± 1.42 28.9 ± 1.97 29.5 ± 1.23 31.1 ± 2.72 27.8 ± 2.19
Control 25.0 ± 1.60 24.8 ± 1.17 26.4 ± 1.39 29.4 ± 0.70 29.6 ± 1.25 28.5 ± 1.10 27.7 ± 0.65
Figure 6. Changes in lactose concentration of the infected quart-
ers of recombinant bST-treated cows ( Ú) and control cows ( ×)
during experimentally induced Streptococcus uberis mastitis. Data
are means of five cows, and error bars represent the standard
errors of the means. Periods: ±1 = d ±8 until 0 h, 0 = 6 to 24 h after
infection, 1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection,
3 = from 78 to 96 h after infection, 4 = d +6 to +9, 5 = d +14 to +28.
Figure 7. Changes in total protein concentration of the infected
quarters of recombinant bST-treated cows ( Ú) and control cows ( ×)
during experimentally induced Streptococcus uberis mastitis. Data
are means of five cows, and error bars represent the standard
errors of the means. Periods: ±1 = d ±8 until 0 h, 0 = 6 to 24 h after
infection, 1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection,
3 = from 78 to 96 h after infection, 4 = d +6 to +9, 5 = d +14 to +28.
0.001) in the control group was observed between 24
and 72 h after infection. Although BSA began to
decrease around 72 h postinfection in the treated
group, on d +7, the concentration of BSA in milk was
still higher than the preinfection concentration for
cows in the treated group ( P < 0.05) and in the
control group ( P < 0.01). This slow decrease con-
tinued until the end of the experiment. In contrast,
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Figure 8. Changes in the concentration of BSA of the infected
quarters of recombinant bST-treated cows ( Ú) and control cows ( ×)
during experimentally induced Streptococcus uberis mastitis. Data
are means of five cows, and error bars represent the standard
errors of the means. Periods: ±1 = d ±8 until 0 h, 0 = 6 to 24 h after
infection, 1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection,
3 = from 78 to 96 h after infection, 4 = d +6 to +9, 5 = d +14 to +28.
Figure 9. Changes in Na+ concentration of the infected quarters
of recombinant bST-treated cows ( Ú) and control cows ( ×) during
experimentally induced Streptococcus uberis mastitis. Data are
means of five cows, and error bars represent the standard errors of
the means. Periods: ±1 = d ±8 until 0 h, 0 = 6 to 24 h after infection,
1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection, 3 = from
78 to 96 h after infection, 4 = d +6 to +9, 5 = d +14 to +28.
after 72 h postinfection, BSA decreased ( P < 0.05) in
the control group but increased ( P < 0.05) again
between d +6 and +9. After this short episode of
increased concentrations, BSA continued to decrease
( P < 0.01) during the next week. No complete recov-
ery could be accomplished in either group. The con-
centration on d +28 was still higher ( P < 0.001) than
the preinfection concentration.
During the first 24 h after infection, an increase ( P
< 0.05) in BSA was observed in the contralateral
control quarters of both groups, peaking ( P < 0.001)
at 72 h postinfection in the treated group. After this
maximum, BSA decreased ( P < 0.01) in the treated
cows. One week after infection, the concentration in-
creased ( P < 0.001) again toward concentrations ob-
served at 72 h postinfection. During the last 3 wk of
the experiment, the concentration decreased ( P <
0.05) toward a level that was still higher ( P < 0.001)
than the preinfection value. In the control cows, an
increase toward a maximum at 48 h was observed ( P
< 0.01) followed by a second increase ( P < 0.001)
between d +6 and +9 postinfection, which was fol-
lowed by a decrease ( P < 0.001) during the last 3 wk
of the trial toward a concentration that was still
higher ( P < 0.05) than those before infection.
Milk Na+
During the first 24 h after infection, Na+ concentra-
tion did not alter ( P > 0.05) in either group (Figure
9), but increased ( P < 0.05) during the next 24 h in
the control group. Between 54 and 72 h postinfection,
a three- and fourfold increase was observed in the
treated and control cows. After this peak, Na+ slowly
decreased toward values that were still higher than
preinfection values in the treated ( P < 0.01) and the
control groups ( P < 0.05) on d +28.
No changes ( P > 0.05) could be observed in the
contralateral control quarters of treated cows (Table
1).
Milk K+
During the first 24 h after infection, milk K+ con-
centration decreased 24 and 27% in the treated ( P <
0.01) and control cows ( P < 0.001) (Figure 10); the
lowest values were observed between 30 and 48 h
postinfection. In the treated group, K+ concentrations
remained lower ( P < 0.001) than preinfection concen-
trations from 6 to 48 h postinfection. Milk K+ in the
control group over the complete postinfection period
was lower ( P < 0.05) than the preinfection concentra-
tion. In the control group, recovery by the end of the
experiment was not complete ( P < 0.05).
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Figure 10. Changes in K+ concentration of the infected quarters
of recombinant bST-treated cows ( Ú) and control cows ( ×) during
experimentally induced Streptococcus uberis mastitis. Data are
means of five cows, and error bars represent the standard errors of
the means. Periods: ±1 = d ±8 until 0 h, 0 = 6 to 24 h after infection,
1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection, 3 = from
78 to 96 h after infection, 4 = d +6 to +9, 5 = d +14 to +28.
Figure 11. Changes in CL± concentration of the infected quart-
ers of recombinant bST-treated cows ( Ú) and control cows ( ×)
during experimentally induced Streptococcus uberis mastitis. Data
are means of five cows, and error bars represent the standard
errors of the means. Periods: ±1 = d ±8 until 0 h, 0 = 6 to 24 h after
infection, 1 = 30 to 48 h after infection, 2 = 54 to 72 h after infection,
3 = from 78 to 96 h after infection, 4 = d +6 to +9, 5 = d +14 to +28.
In the contralateral control quarters, K+ concentra-
tion decreased 10 and 17% during the first 24 h
postinfection in the treated ( P < 0.05) and the control
groups ( P < 0.001) (Table 1), remained lower ( P <
0.01) until 48 h, then increased ( P < 0.001) in both
groups after 54 h. Recovery by the end of the study
was complete. In the control group, the overall postin-
fection concentration was lower ( P < 0.05) than the
preinfection concentration.
Milk Cl–
Milk Cl± concentration increased twofold ( P <
0.05) in the treated group and increased 2.3-fold ( P <
0.01) in the control group (Figure 11). Peak values
occurred between 54 and 84 h after infection. At the
end of the trial, the concentration was still higher ( P
< 0.001) than that before infection in both groups,
indicating that recovery was not complete. In the
control group, the concentration over the entire
postinfection period was higher ( P < 0.05) than the
preinfection concentration.
In the contralateral control quarters, Cl± increased
( P < 0.01) in both groups between 54 and 72 h after
infection (Table 1) and remained elevated until d +9.
No difference ( P > 0.05) could be observed between
preinfection and postinfection Cl± concentrations in
either group. General and Local Clinical Symptoms
The general and local clinical symptoms are dis-
cussed more extensively in a companion paper (19).
At 24 h after intramammary inoculation of S. uberis,
the infected quarters were swollen. Between 24 and
48 h postinfection, the firmness of the infected quart-
ers significantly increased, especially in the control
cows. Flakes and clots appeared in the milk of the
infected quarters from 30 h after infection, especially
in the control cows, and disappeared in some cows
only after 9 d. In the most severely diseased cows the
milk became watery and yellow. Symptoms of pain
appeared from about 36 h after infection and disap-
peared 1 wk after infection. Local symptoms were
more pronounced and of longer duration in the control
cows. The appearance of local signs in the treated
cows occurred later than in the control cows.
Local symptoms were accompanied by general sym-
ptoms such as fever, tachycardia, and mild depres-
sion. In the treated cows, fever was observed between
6 and 30 h after infection and peaked at 39.4 ±
0.19°C. In the control cows, fever was observed be-
tween 1 and 3 d after infection and peaked at 40.3 ±
0.14°C. Rectal temperature showed several fluctua-
tions, especially in the control group. Tachycardia
was observed between 24 and 48 h after infection in
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the control group and between 48 and 72 h after
infection in the treated group. Loss of appetite and
rumen motility was not observed ( P > 0.05).
For ethical reasons, cows had to be treated with
antibiotics, but, to minimize interference with the
effects of bST, this antibiotic treatment was post-
poned as long as possible. All cows in the control
group were treated for the first time on d +6 for 3
consecutive d. One cow received a second treatment
on d +14. In the treated group, 4 cows were treated
for the first time on d +6. The 5th cow received her
treatment on d +10. One cow was treated for a second
time on d +17.
DISCUSSION
The administration of recombinant bST (Posilac)
in healthy cows subsequently infected with ex-
perimental S. uberis mastitis was associated with a
positive effect upon changes in MP and milk composi-
tion. Injection of bST in healthy cows induced an
increase in MP after 2 d and a plateau around 4 to 5 d
after injection, which is comparable with the results
of French et al. (11), who observed an increase by
14% and a plateau after 5 to 6 d. Decreases in MP of
the contralateral control quarters after experimental
infection were only minor compared with the
decreases in total MP and MP of the infected quart-
ers. This result might suggest that the systemic im-
pact of S. uberis mastitis is very low, which is in
contrast to E. coli mastitis. Indeed, in the E. coli
experiment of Vandeputte-Van Messom and Bur-
venich (47), the decline in MP of the uninfected
quarters was much higher (32 and 61% for moderate
and severe responders) than the MP losses of the
contralateral quarters observed during S. uberis
mastitis (14%). The decrease in total MP and MP in
the infected and contralateral quarters during the 3rd
wk after the second treatment indicates that this
sustained-release form of recombinant bST exerts its
effect during 2 wk. Pretreatment with bST of healthy
cows subsequently intramammarily infected with S.
uberis has a positive effect on the MP losses during
mastitis and the recovery of MP after mastitis.
Vandeputte-Van Messom and Burvenich (47)
reported similar findings during experimental E. coli
mastitis.
We observed a time interval of 2 to 3 d between the
administration of bST in healthy cows and the in-
crease in MP, which is in agreement with the results
of others (11, 32, 33). The reduced synthesis of fatty
acids in adipose tissues 3 d after bST administration
(49) supports the theory of repartitioning of
nutrients by bST (11, 30, 51) as a mechanism by
which bST increases MP in healthy mammary glands.
The inflamed mammary gland appears to be suscepti-
ble for the galactopoietic effect of somatotropin,
although the mammary epithelial cells and the blood-
milk barrier are damaged. The mechanism by which
bST is able to increase MP of an inflamed gland is not
completely understood. The presence of receptors for
IGF-I and somatotropin on mammary tissue might be
involved (2, 6, 12).
The increase in SCC after infection and the return
to normal values at the end of the trial occurred
earlier and faster in the control cows, and recovery
was complete in the latter. This result is in contrast
to the results of the E. coli trial of Vandeputte-Van
Messom and Burvenich (47), who observed a faster
influx of leukocytes into milk in the bST-treated cows.
Recombinant bST appeared to slow down the influx of
defense cells during a subsequent experimental S.
uberis infection. A high neutrophil influx induces se-
vere damage during S. uberis mastitis, and the rate of
influx of polymorphonuclear leukocytes during E. coli
mastitis is determinant for the outcome and severity
of E. coli mastitis (17). Neutrophils are ineffective at
controlling infection caused by S. uberis (16);
however, macrophages are important (46). Treat-
ment with bST had no effect on the recovery of SCC
in both the E. coli and S. uberis mastitis studies. In
healthy cows, bST has no effect on SCC (29), except
in very high dosages of >960 mg/28 d. In the present
experiment, the treated cows received about 1000 mg/
28 d, which is indeed higher than the highest dosage
in the study of McGlary et al. (29). These dosages
may induce an increase in SCC, which might explain
why the SCC in the treated cows was higher com-
pared with the control cows during the last week of
the experiment. Elvinger et al. ( 8 ) could not detect
stimulating effects of somatotropin on the migration
and chemotaxis of polymorphonuclear leukocytes,
although McGlary et al. (29) and Burvenich et al.
( 4 ) suggested an increased diapedesis of polymor-
phonuclear leukocytes from the circulation to the
mammary gland by bST.
The effect of bST on bacterial counts in milk could
only be estimated during the first 6 d after infection
because all cows received antibiotic therapy 48 h after
appearance of clinical symptoms. Bovine
somatotropin had no bacteriostatic or bactericidal ef-
fects. However, treatment of cows with bST induces
an increased concentration of IGF-I (5, 19, 36, 44).
Fattal et al. (10) showed that IGF-I is involved in the
posttranscriptional modulation of the activity of the
plasminogen activator inhibitor type 1 by prolonging
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the mRNA half-life. As a consequence, the activation
of plasminogen to plasmin is decreased. Because of
this decrease, fewer amino acids become available for
the bacteria, which suppresses their growth. Indeed,
S. uberis is an auxotrophic agent, and its growth
depends on the acquisition of essential amino acids
which become available by the proteolytic effect of
plasmin (22, 27). Because of this decreased availabil-
ity of essential amino acids, the growth of S. uberis
may be inhibited after bST treatment.
Politis et al. (34) demonstrated an inverse rela-
tionship between the concentration of plasmin in milk
and somatotropin. During mastitis, the concentration
of plasmin and plasminogen increases in milk by
damage of the epithelial cells with disruption of the
tight junctions and leakage of blood plasmin and
plasminogen into the milk (paracellular transport)
(37, 38). Also, an increase in the SCC is associated
with increased plasmin activity in milk (35).
However, it is unlikely that plasminogen activators
from these cells contribute to the increased plasmin
concentration. In the bST-treated cows, this increased
plasmin activity may be counteracted by the increase
in IGF-I, which might explain the lower amount of
bacteria in the treated cows. It is highly unlikely that
the intrinsic plasmin activator activity of S. uberis
(23, 24) is reduced by the stimulating effect of IGF-I
on the plasminogen activator inhibitor type 1.
Concerning the milk composition, the most promi-
nent effects were observed in the infected quarters.
Only minor changes could be observed in the con-
tralateral quarters. The decrease in lactose concentra-
tion in the control cows could be due to leakage
toward the circulation, to decreased production by the
damaged mammary epithelial cells, and to an in-
crease in consumption by the multiplying S. uberis in
the mammary gland. In contrast with the control
cows, no significant changes could be observed in the
fat concentration of the infected and contralateral
quarters of the treated cows. Fat concentration was
completely normal 4 wk after infection in both groups.
The significantly more pronounced changes in protein
concentration of the infected quarters of the control
cows were mainly due to the influx of BSA into the
mammary gland.
However, the increase in total milk protein cannot
be completely explained by the increase in BSA,
which indicates that other inflammation-related pro-
teins (e.g., acute phase proteins) appear in the milk.
The high concentrations at the end of the experiment
might be due to increased concentrations of im-
munoglobulins and other inflammation-related pro-
teins and to an influx of BSA. Although BSA in-
creased in the control quarters, a decrease in total
milk protein was observed, which was probably due to
a decreased production of milk proteins. The reduc-
tion in milk proteins might be due to a decreased
absorption of amino acids in the gut and to a redirec-
tion of the use of amino acids toward immunoglobu-
lins. Because of the increased proteolytic activity of
the milk during mastitis (1, 7, 20, 37), which is
mainly due to increased plasmin activity, caseins are
hydrolyzed. These changes in milk composition indi-
cate serious damage to the blood-milk barrier with
disruption of the tight junctions between mammary
epithelial cells and paracellular leakage (43). Ad-
ministration of recombinant bST appears to protect
this barrier from excessive damage because the com-
position changes in the treated cows were less
pronounced. The lack of a complete recovery of the
concentration of milk protein, BSA, and lactose indi-
cates that the integrity of the damaged blood-milk
barrier was not completely restored 4 wk after infec-
tion.
Changes in the concentration of Na+, K+, and Cl± in
the infected quarters were more prominent in the
control cows. These changes also suggest damage of
the blood-milk barrier. At the end of the experiment,
Na+ and Cl± concentration were still significantly
higher than preinfection concentrations in both
groups and K+ only in the control group. Treatment
with recombinant bST protected the mammary gland
from excessive losses in MP and compositional
changes. However, in both groups, 4 wk after infec-
tion, the damaged blood-milk barrier was still not
completely restored, even in the bST-treated cows.
Indeed, the concentrations of lactose, protein, BSA,
Na+, and Cl± in the infected quarters of both groups
were still significantly different from the concentra-
tions observed before infection.
The mechanism by which the integrity of the blood-
milk barrier is preserved and restored is not under-
stood. Positive effects of IGF-I on the cytoskeleton of
the epithelial cells and on the tight junctions between
these cells may be important. Indeed, effects of IGF-I
or somatotropin on the cytoskeleton, tubulin mRNA,
and cytoskeletal reorganization have been reported in
rats (3, 13) and humans (21, 50). Ericson and Nils-
son ( 9 ) studied the effect of IGF-I on the epithelial
barrier in polarized pig thyrocyte monolayers. Indeed,
IGF-I receptors ( 2 ) and growth hormone receptors
(12) have been observed on mammary tissue.
Insulin-like growth factor I increased the tran-
sepithelial potential difference without significant
changes in the transepithelial resistance. Similar
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studies could be performed in a cell culture model of
the blood-milk barrier (41).
Because neutrophils contribute little to the patho-
genesis of S. uberis mastitis (17), which is in contrast
to E. coli mastitis, the possible positive effects of bST
on several neutrophil functions, as suggested by
Vandeputte-Van Messom and Burvenich (47) but not
confirmed by Elvinger et al. (8) , are probably not
responsible for the observed beneficial effect of recom-
binant bST during experimental S. uberis mastitis.
In conclusion, treatment of healthy cows with bST
protects cows from excessive MP losses and excessive
milk compositional changes during a subsequent ex-
perimental intramammary infection with S. uberis.
Although not complete, the recovery of MP and milk
composition was markedly improved by protective
and postinfection treatment with bST. The protective
role of bST is not restricted to E. coli mastitis only,
and bST is important in the homeostasis of inflamma-
tion of the mammary gland.
ACKNOWLEDGMENTS
This study was supported by the Belgian Ministry
of Agriculture (Brussels; grant number D1/2-5471A).
The authors thank K. Van Oosveldt, A. Diez, M.-R.
De Smet, E. Vander Elstraeten, and L. De Bruyne for
their excellent technical assistance. The authors also
extend their appreciation to L. Devriese (Laboratory
for Bacteriology, Faculty of Veterinary Medicine,
University of Ghent, Ghent, Belgium) for culturing
the S. uberis strain and to J. A. Leigh (Institute for
Animal Health, Compton, Newbury, Berks, UK) for
supplying the S. uberis O140J. We also thank M. T.
Ysebaert for advice on the statistical analysis.
REFERENCES
1 Andrews, A. T. 1983. Breakdown of caseins by proteinases in
bovine milks with high somatic cell counts arising from mastitis
or infusion with bacterial endotoxin. J. Dairy Res. 50:57±66.
2 Baumrucker, C. R., and B. H. Stemberger. 1989. Insulin and
insulin-like growth factor-I stimulate DNA synthesis in bovine
mammary tissue in vitro. J. Anim. Sci. 67:3503±3514.
3 Berfield, A. K., D. Spicer, and C. K. Abrass. 1997. Insulin-like
growth factor I (IGF-I) induces unique effects in the cytoskele-
ton of cultured rat glomerular mesangial cells. J. Histochem.
Cytochem. 45:583±593.
4 Burvenich, C., G. Vandeputte-Van Messom, E. Roets, J. Fabry,
and A. M. Massart-LeeÈn. 1989. Effect of bovine somatotropin on
milk yield and milk composition in periparturient cows ex-
perimentally infected with Escherichia coli. Page 277 in Use of
Somatotropin in Livestock Production. K. Sejrsen, M. Vester-
gaard, and A. Neimann-Sorensen, ed. Elsevier Appl. Sci., New
York, NY.
5 Davis, S. R., P. D. Gluckman, I. C. Hart, and H. V. Henderson.
1989. Effects of injecting growth hormone or thyroxine on milk
production and blood plasma concentrations of insulin-like
growth factors I and II in dairy cows. J. Endocrinol. 114:17±24.
6 Dehoff, M. H., R. G. Elgin, R. J. Collier, and D. R. Clemmons.
1988. Both type I and II insulin-like growth factor receptor
binding increase during lactogenesis in bovine mammary tis-
sue. Endocrinology 122:2412±2417.
7 De Rham, O., and A. T. Andrews. 1982. Qualitative and quan-
titative determination of proteolysis in mastitic milks. J. Dairy
Res. 49:587±596.
8 Elvinger, F., P. J. Hansen, H. H. Head, and R. P. Natzke. 1991.
Actions of bovine somatotropin on polymorphonuclear leuko-
cytes and lymphocytes in cattle. J. Dairy Sci. 74:2145±2152.
9 Ericson, L. E., and M. Nilsson. 1996. Effects of insulin-like
growth factor I on growth, epithelial barrier and iodide trans-
port in polarized pig thyrocyte monolayers. Eur. J. Endocrinol.
135:118±127.
10 Fattal, P. G., D. J. Schneider, B. E. Sobel, and J. J. Billadello.
1992. Post-transcriptional regulation of expression of plasmino-
gen activator inhibitor type 1 mRNA by insulin and insulin-like
growth factor 1. J. Biol. Chem. 267:12412±12415.
11 French, N., G. De Boer, and J. J. Kennelly. 1990. Effects of
feeding frequency and exogenous somatotropin on lipolysis,
hormone profiles, and milk production in dairy cows. J. Dairy
Sci. 73:1552±1559.
12 Glimm, D. R., V. E. Baracos, and J. J. Kennelly. 1990. Molecu-
lar evidence for the presence of growth hormone receptors in
the bovine mammary gland. J. Endocrinol. 126:R5±8.
13 Goh, E. L., T. J. Pircher, T. J. Wood, G. Norstedt, R. Graichen,
and P. E. Lobie. 1997. Growth hormone-induced reorganization
of the actin cytoskeleton is not required for STAT5 (signal
transducer and activator of transcription-5)-mediated tran-
scription. Endocrinology 138:3207±3215.
14 Guzman, A. A., M. D. PeÂrez, R. M. Marquez, and J. R. Garza.
1986. Colorimetric determination of bovine serum albumin
(BSA) in milk using bromcresol green dye. J. Dairy Sci.
(Suppl. 1)69:102. (Abstr.)
15 Hamann, J. 1997. How much is enough? Milk quality and milk
quantity as regulatory elements for mastitis research. Pages
63±84 in A Half Centenary of Lactation Biology and Pathology
Research. C. Burvenich, A. J. Guidry, and D. Hoeben, ed. Flem.
Vet. J., Merelbeke, Belgium.
16 Hill, A. W., J. M. Finch, T. R. Field, and J. A. Leigh. 1994.
Immune modification of the pathogenesis of Streptococcus
uberis mastitis in the dairy cow. FEMS Immunol. Microbiol. 8:
109±118.
17 Hill, A. W., A. L. Shears, and K. G. Hibbitt. 1979. The pathogen-
esis of experimental Escherichia coli mastitis in newly calved
dairy cows. Res. Vet. Sci. 26:97±101.
18 Hillerton, J. E. 1997. UK research to control mastitisÐsome
significant advances changing the aetiology and incidence of
mastitis today Pages 33±49 in A Half Centenary of Lactation
Biology and Pathology Research. C. Burvenich, A. J. Guidry,
and D. Hoeben, ed. Flem. Vet. J., Merelbeke, Belgium.
19 Hoeben, D., C. Burvenich, E. Smits, P. J. Eppard, and D. L.
Hard. 1999. Effect of bovine somatotropin on neutrophil func-
tions and clinical symptoms during Streptococcus uberis masti-
tis. J. Dairy Sci. 82:000±000.
20 Kaartinen, L., and M. Sandholm. 1987. Regulation of plasmin
activation in mastitic milk. Correlation with inflammatory mar-
kers and growth of Streptococcus agalactiae. J. Vet. Med. Ser. B
34:42±50.
21 Kadowaki, T., S. Koyasu, E. Nishida, H. Sakai, F. Takaku, I.
Yahara, and M. Kasuga. 1986. Insulin-like growth factors, insu-
lin, and epidermal growth factor cause rapid cytoskeletal reor-
ganization in KB cells. Clarification of the roles of type I
insulin-like growth factor receptors and insulin receptors. J.
Biol. Chem. 261:16141±16147.
22 Kitt, A. J., and J. A. Leigh. 1997. The auxotrophic nature of
Streptococcus uberis: the acquisition of essential amino acids
from plasmin derived casein peptides. Adv. Exp. Med. Biol. 418:
647±650.
23 Leigh, A. J. 1993. Activation of bovine plasminogen by Strep-
tococcus uberis. FEMS Microbiol. Lett. 114:67±72.
Journal of Dairy Science Vol. 82, No. 8, 1999
STREPTOCOCCUS UBERIS MASTITIS AND SOMATOTROPIN 1683
24 Leigh, A. J. 1994. Purification of a plasminogen activator from
Streptococcus uberis. FEMS Microbiol. Lett. 118:153±158.
25 Leigh, A. J., and T. R. Field. 1991. Killing of Streptococcus
uberis by bovine neutrophils following growth in chemically
defined media. Vet. Res. Commun. 15:1±6.
26 Leigh, A. J., and T. R. Field. 1994. Streptococcus uberis resists
the bactericidal action of bovine neutrophils despite the
presence of bound immunoglobulin. Infect. Immun. 62:
1854±1859.
27 Leigh, A. J., and R. A. Lincoln. 1997. Streptococcus uberis
acquires plasmin activity following growth in the presence of
bovine plasminogen through the action of its specific plasmino-
gen activator. FEMS Microbiol. Lett. 154:123±129.
28 McBride, B. W., J. L. Burton, and J. H. Burton. 1988. Review:
the influence of bovine growth hormone (bST) on animals and
their products. Res. Dev. Agric. 5:1±21.
29 McGlary, D. G., H. B. Green, R. P. Basson, and S. C. Nickerson.
1994. The effects of a sustained-release recombinant bovine
somatotropin (Somidobove) on udder health for a full lactation.
J. Dairy Sci. 77:2261±2271.
30 Miller, P. S., B. L. Reis, C. C. Calvert, E. J. DePeters, and R. L.
Baldwin. 1991. Relationship of early lactation and bovine
somatotropin on nutrient uptake by cow mammary glands. J.
Dairy Sci. 74:3800±3806.
31 Peel, C. J., and D. E. Bauman. 1987. BST and lactation. J.
Dairy Sci. 70:474±486.
32 Peel, C. J., D. E. Bauman, R. C. Gorewit, and C. J. Sniffen.
1981. Effect of exogenous growth hormone on lactational perfor-
mance in high yielding dairy cows. J. Nutr. 111:1662±1671.
33 Peel, C. J., T. J. Fronk, D. E. Bauman, and R. C. Gorewit. 1983.
Effect of exogenous growth hormone in early and late lactation
on lactational performance of dairy cows. J. Dairy Sci. 66:
776±782.
34 Politis, I., E. Block, and J. D. Turner. 1990. Effect of
somatotropin on the plasminogen and plasmin system in the
mammary gland: proposed mechanism of action for
somatotropin on the mammary gland. J. Dairy Sci. 73:
1494±1499.
35 Politis, I., E. Lachance, E. Block, and J. D. Turner. 1989.
Plasmin and plasminogen in bovine milk: a relationship with
involution. J. Dairy Sci. 72:900±906.
36 Prosser, C. G., I. R. Fleet, and A. N. Corps. 1989. Increased
secretion of insulin-like growth factor-I into the milk of cows
treated with recombinantly derived bovine growth hormone. J.
Dairy Res. 56:17±26.
37 Saeman, A. I., R. J. Verdi, D. M. Barbano, and D. M. Galton.
1988. Effect of mastitis on proteolytic activity in bovine milk. J.
Dairy Sci. 71:505±512.
38 Schaar, J., and H. Funke. 1986. Effect of mastitis on milk
plasminogen and plasmin compared with that on sodium, an-
titrypsin and N-acetyl-b-D-glucosaminidase. J. Dairy Res. 53:
515±528.
39 Smith, K. L., and J. S. Hogan. 1993. Environmental mastitis.
Vet. Clin. North Am. Food Anim. Pract. 9:489±498.
40 Smith, K. L., and J. S. Hogan. 1997. Future prospects for
mastitis control. Pages 389±402 in A Half Centenary of Lacta-
tion Biology and Pathology Research. C. Burvenich, A. J.
Guidry, and D. Hoeben, ed. Flem. Vet. J., Merelbeke, Belgium.
41 Smits, E., E. Cifrian, A. J. Guidry, P. Rainard, C. Burvenich,
and M. J. Paape. 1996. Cell culture system for studying bovine
neutrophil diapedesis. J. Dairy Sci. 79:1353±1360.
42 Statistix User's Manual: Version 4.0. 1992. Analytical Soft-
ware, Tallahassee, FL.
43 Stelwagen, K., S. R. Davis, V. C. Farr, C. G. Prosser, and R. A.
Sherlock. 1994. Mammary epithelial cell tight junction integrity
and mammary blood flow during an extended milking interval
in goats. J. Dairy Sci. 77:426±432.
44 Stelwagen, K., D. G. Grieve, J. S. Walton, J. L. Ball, and B. W.
McBride. 1993. Effect of prepartum bovine somatotropin in
primigravid ewes on mammogenesis, milk production, and hor-
mone concentrations. J. Dairy Sci. 76:992±1001.
45 Thomas, J. W., R. A. Erdman, D. M. Galton, R. C. Lamb, M. J.
Arambel, J. D. Olson, K. S. Madsen, W. A. Samuels, C. J. Peel,
and G. A. Green. 1991. Responses by lactating cows in commer-
cial dairy herds to recombinant bovine somatotropin. J. Dairy
Sci. 74:945±964.
46 Thomas, L. H., W. Haider, A. W. Hill, and R. S. Cook. 1994.
Pathologic findings of experimentally induced Streptococcus
uberis infection in the mammary gland of cows. Am. J. Vet. Res.
55:1723±1729.
47 Vandeputte-Van Messom, G., and C. Burvenich. 1993. Effect of
somatotropin on changes in milk production and composition
during coliform mastitis in periparturient cows. J. Dairy Sci.
76:3727±3741.
48 Vandeputte-Van Messom, G., A. M. Massart-LeeÈn, and C. Bur-
venich. 1989. Endocrinological changes in newly calved cows
during experimentally induced E. coli mastitis. Page 346 in
Proc. 7th Int. Conf. Prod. Dis. Farm. Anim., Cornell Univ.,
Ithaca, NY.
49 Vernon, R. G. 1982. Effects of growth hormone on fatty acid
synthesis in sheep adipose tissue. Int. J. Biochem. 14:255±258.
50 Wang, C., Y. Li, B. Wible, K. J. Angelides, and D. N. Ishii. 1992.
Effects of insulin and insulin-like growth factors on neurofila-
ment mRNA and tubulin mRNA content in human neurob-
lastoma SH-SY5Y cells. Brain Res. Mol. Brain. Res. 13:289±300.
51 West, J. W., K. Bondari, and J. C. Johnson, Jr. 1990. Effects of
bovine somatotropin on milk yield and composition, body
weight, and condition score of Holstein and Jersey cows. J.
Dairy Sci. 73:1062±1068.
